Occult central nervous system involvement in patients with metastatic breast cancer: Prevalence, predictive factors and impact on overall survival

Annals of Oncology

Volumn 14, Issue 7, 2003, Pages 1072-1077

  Miller, Kath D ^a   Weathers, T ^a   Haney, L G ^a   Timmerman, R ^a   Dickler, M ^b   Shen, J ^a   Sledge Jr , G W ^a  

^a INDIANA UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; Central nervous system; Metastasis; Natural history

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTHRACYCLINE; CAPECITABINE; DOCETAXEL; EPIRUBICIN; MONOCLONAL ANTIBODY; PACLITAXEL; RECOMBINANT ANTIBODY; TAXANE DERIVATIVE; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; ONCOGENE NEU; PREDICTION; PREVALENCE; PRIORITY JOURNAL;

EID: 0042200720     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg300     Document Type: Article

References (25)

1. DiStefano A, Yong Yap Y, Hortobagyi GN et al. The natural history of breast cancer patients with brain metastases. Cancer 1979; 44: 1913-1918.
2. Zimm S, Wampler GL, Stablein D et al. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 1981; 48: 384-394.
3. Hall WA, Djalilian HR, Nussbaum ES et al. Long-term survival with metastatic cancer to the brain [citation]. Med Oncol 2000; 17: 279-286.
4. Sinard JH. Factors affecting autopsy rates, autopsy request rates, and autopsy findings at a large academic medical center. Exp Mol Pathol 2001; 70: 333-343.
5. Gordon MS, Margolin K, Talpaz M et al. Phase I safety and pharmacokinetic Study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol 2001; 19: 843-850.
6. Tsukada Y, Fouad A, Pickren JW et al. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 1983; 52: 2349-2354.
7. Amer M. Chemotherapy and pattern of metastases in breast cancer patients. J Surg Oncol 1982; 19: 101-105.
8. Hagemeister F, Buzdar A, Luna M et al. Causes of death in breast cancer. Cancer 1980; 46: 162-167.
9. Ahmann FR, Jones SE, Moon TE. The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer. J Surg Oncol 1988; 37: 116-122.
10. Carey L, Ewend M, Sawyer L et al. Disproportionate CNS relapse after aggressive neoadjuvant chemotherapy. Breast Cancer Res Treat 2001; 69: 299.
11. Crivellari D, Pagani O, Veronesi A et al. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol 2001; 12: 353-356.
12. Freilich RJ, Seidman AD, DeAngelis LM. Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer 1995; 76: 232-236.
13. Muss HB, White DR, Cowan RJ. Brain scanning in patients with recurrent breast cancer. Cancer 1976; 38: 1574-1576.
14. Lower E, Blau R, Bismayer J et al. Increased brain metastasis detected in metastatic breast cancer patients receiving Herceptin. Breast Cancer Res Treat 2001; 69: 271.
15. Aronson S, Garcia J, Aronson B. Metastatic neoplasms of the brain: their frequency in relation to age. Cancer 1964; 5: 558-563.
16. de la Monte S, Hutchins G, Moore G. Influence of age on the metastatic behavior of breast carcinoma. Hum Pathol 1988; 19: 529-534.
17. Taphoorn MJ, Heimans JJ, Kaiser MC et al. Imaging of brain metastases. Comparison of computerized tomography (CT) and magnetic resonance imaging (MRI). Neuroradiology 1989; 31: 391-395.
18. Davis PC, Hudgins PA, Peterman SB et al. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. Am J Neuroradiol 1991; 12: 293-300.
19. Lesse S, Netsky M. Metastasis of neoplasms to the central nervous system and meninges. Arch Neurol Psychiat 1954; 72: 133-153.
20. Abrams H, Spiro R, Goldstein N. Metastasis in carcinoma: analysis of 1000 autopsied cases. Cancer 1950; 3: 74-85.
21. Viadana E, Cotter R, Pickren JW et al. An autopsy study of metastatic sites of breast cancer. Cancer Res 1973; 33: 179-181.
22. Cifuentes N, Pickren JW. Metastases from carcinoma of mammary gland: an autopsy study. J Surg Oncol 1979; 11: 193-205.
23. Cho SY, Choi HY. Causes of death and metastatic patterns in patients with mammary cancer. Ten-year autopsy study. Am J Clin Pathol 1980; 73: 232-234.
24. Posner J, Chernik N. Intracranial metastases from systemic cancer. Adv Neurol 1978; 19: 579-591.
25. Lamvec J, Zidar A. Association of leptomeningeal carcinomatosis in carcinoma of the breast with infiltrating lobular carcinoma. Arch Pathol Lab Med 1991; 115: 507-510.